Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Previously Treated Non-Small Cell Lung Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT02474355
What this trial is testing

Real World Treatment Study of AZD9291 for Advanced/Metastatic EGFR T790M Mutation NSCLC

Who this might be right for
Lung Cancer
AstraZeneca 3,017
Early research (Phase 1)Study completedNCT01957007
What this trial is testing

Vantictumab (OMP-18R5) in Combination With Docetaxel in Patients With Previously Treated NSCLC

Who this might be right for
Solid Tumors
OncoMed Pharmaceuticals, Inc. 34
Large-scale testing (Phase 3)Looking for participantsNCT07361510
What this trial is testing

Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)

Who this might be right for
Non-Small Cell Lung Cancer (NSCLC)
Bristol-Myers Squibb 750
Testing effectiveness (Phase 2)Study completedNCT03158129
What this trial is testing

Nivolumab With or Without Ipilimumab or Chemotherapy in Treating Patients With Previously Untreated Stage I-IIIA Non-small Cell Lung Cancer

Who this might be right for
Stage I Lung Non-Small Cell Cancer AJCC v7Stage IA Lung Non-Small Cell Carcinoma AJCC v7Stage IB Lung Non-Small Cell Carcinoma AJCC v7+4 more
M.D. Anderson Cancer Center 101
Testing effectiveness (Phase 2)Active Not RecruitingNCT06933329
What this trial is testing

Zelenectide Pevedotin in NECTIN4 Amplified Advanced or Metastatic Non-small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
BicycleTx Limited 73
Testing effectiveness (Phase 2)Ended earlyNCT00372073
What this trial is testing

Efficacy Study of Oral Seliciclib to Treat Non-Small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Cyclacel Pharmaceuticals, Inc. 187
Testing effectiveness (Phase 2)Ended earlyNCT03228186
What this trial is testing

Trial of Pevonedistat Plus Docetaxel in Patients With Previously Treated Advanced Non-Small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
University of Michigan Rogel Cancer Center 40
Testing effectiveness (Phase 2)UnknownNCT03726736
What this trial is testing

Anlotinib Combined With Docetaxel Versus Docetaxel for Previous Treated Advanced NSCLC

Who this might be right for
Non-small Cell Lung Cancer
Yong Fang 97
Testing effectiveness (Phase 2)WithdrawnNCT02661100
What this trial is testing

A Trial of CDX-1401 in Combination With Poly-ICLC and Pembrolizumab, in Previously Treated Advanced Solid Tumor Patients

Who this might be right for
Non Small Cell Lung CancerAdvanced Triple Negative Breast CancerSmall Cell Lung Cancer+3 more
Case Comprehensive Cancer Center
Not applicableStudy completedNCT00445952
What this trial is testing

Natural History Study of Fungal Infections of the Blood in Patients With Cancer or in Patients Who Have Undergone a Stem Cell Transplant

Who this might be right for
Cancer
European Organisation for Research and Treatment of Cancer - EORTC 304
Testing effectiveness (Phase 2)Looking for participantsNCT06780098
What this trial is testing

Substudy 01I: A Study of Investigational Agents in Participants With Previously Treated Stage IV Squamous Non-small Cell Lung Cancer (NSCLC) (MK-3475-01I/KEYMAKER-U01I)

Who this might be right for
Lung Neoplasm
Merck Sharp & Dohme LLC 144
Testing effectiveness (Phase 2)UnknownNCT05910034
What this trial is testing

Envafolimab Plus Docetaxel In Combination With or Without Trilaciclib Versus Docetaxel in Advanced NSCLC

Who this might be right for
Advanced Non-Small Cell Lung Cancer
Fudan University 132
Large-scale testing (Phase 3)Looking for participantsNCT06930794
What this trial is testing

Vebreltinib and Platinum-Containing Double Agents in Subjects With MET-Positive

Who this might be right for
Non-Small Cell Lung Cancer
Beijing Pearl Biotechnology Limited Liability Company 300
Testing effectiveness (Phase 2)UnknownNCT02274337
What this trial is testing

Safety, Tolerability, Pharmacokinetics and Anti-tumour Activity of AC0010 in Advanced Non Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
Sun Yat-sen University 100
Large-scale testing (Phase 3)Active Not RecruitingNCT02152631
What this trial is testing

Abemaciclib (LY2835219) in Participants With Previously Treated KRAS Mutated Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
Eli Lilly and Company 453
Early research (Phase 1)Ended earlyNCT02448251
What this trial is testing

Safety, Pharmacokinetic and Preliminary Efficacy Study of AC0010MA in Advanced Non Small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
ACEA Therapeutics, Inc. 28
Post-approval studies (Phase 4)Not Yet RecruitingNCT07671560
What this trial is testing

Efficacy and Safety of Ensartinib Combined With Anlotinib in Lorlatinib-Resistant ALK-Positive NSCLC

Who this might be right for
ALK-positive, Locally Advanced or Metastatic (TNM Stage IIIB-IV) Non-small Cell Lung Cancer That Has Developed Resistance to Prior Treatment With Lorlatinib
Qiming Wang 80
Large-scale testing (Phase 3)Temporarily pausedNCT05378763
What this trial is testing

Poziotinib in Previously Treated Participants With Locally Advanced or Metastatic NSCLC Harboring HER2 Exon 20 Mutations

Who this might be right for
NSCLC
Spectrum Pharmaceuticals, Inc 268
Testing effectiveness (Phase 2)Study completedNCT04167657
What this trial is testing

SinTilimab After Radiation (STAR Study)

Who this might be right for
Carcinoma, Non-Small Cell Lung
Peking Union Medical College Hospital 14
Post-approval studies (Phase 4)Ended earlyNCT00536107
What this trial is testing

Study to Assess Safety/Tolerability/Efficacy of Gefitinib Versus Docetaxel in Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Carcinoma, Non-Small-Cell Lung
AstraZeneca 14
Next Page